A citation-based method for searching scientific literature

Soo Hyun Cho, Yeong Sim Choe, Hee Jin Kim, Hyemin Jang, Yeshin Kim, Si Eun Kim, Seung Joo Kim, Jun Pyo Kim, Young Hee Jung, Byeong C Kim, Suzanne L Baker, Samuel N Lockhart, Duk L Na, Seongbeom Park, Sang Won Seo. Eur J Nucl Med Mol Imaging 2020
Times Cited: 13







List of co-cited articles
75 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
William E Klunk, Robert A Koeppe, Julie C Price, Tammie L Benzinger, Michael D Devous, William J Jagust, Keith A Johnson, Chester A Mathis, Davneet Minhas, Michael J Pontecorvo,[...]. Alzheimers Dement 2015
362
84

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum.
Sung Hoon Kang, Yu Hyun Park, Daun Lee, Jun Pyo Kim, Juhee Chin, Yisuh Ahn, Seong Beom Park, Hee Jin Kim, Hyemin Jang, Young Hee Jung,[...]. Dement Neurocogn Disord 2019
59
53

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
38

Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.
Susan M Landau, Allison Fero, Suzanne L Baker, Robert Koeppe, Mark Mintun, Kewei Chen, Eric M Reiman, William J Jagust. J Nucl Med 2015
184
30

Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
30

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
N Tzourio-Mazoyer, B Landeau, D Papathanassiou, F Crivello, O Etard, N Delcroix, B Mazoyer, M Joliot. Neuroimage 2002
30

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease.
Sanka Amadoru, Vincent Doré, Catriona A McLean, Fairlie Hinton, Claire E Shepherd, Glenda M Halliday, Cristian E Leyton, Paul A Yates, John R Hodges, Colin L Masters,[...]. Alzheimers Res Ther 2020
37
30

Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
Hee Jin Kim, Jin Ju Yang, Hunki Kwon, Changsoo Kim, Jong Min Lee, Phillip Chun, Yeo Jin Kim, Na-Yeon Jung, Juhee Chin, Seonwoo Kim,[...]. Brain 2016
38
30

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Adam S Fleisher, Kewei Chen, Xiaofen Liu, Auttawut Roontiva, Pradeep Thiyyagura, Napatkamon Ayutyanont, Abhinay D Joshi, Christopher M Clark, Mark A Mintun, Michael J Pontecorvo,[...]. Arch Neurol 2011
240
30

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
Milos D Ikonomovic, Chris J Buckley, Kerstin Heurling, Paul Sherwin, Paul A Jones, Michelle Zanette, Chester A Mathis, William E Klunk, Aruna Chakrabarty, James Ironside,[...]. Acta Neuropathol Commun 2016
60
23

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.
Osama Sabri, Marwan N Sabbagh, John Seibyl, Henryk Barthel, Hiroyasu Akatsu, Yasuomi Ouchi, Kohei Senda, Shigeo Murayama, Kenji Ishii, Masaki Takao,[...]. Alzheimers Dement 2015
282
23

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Rik Vandenberghe, Koen Van Laere, Adrian Ivanoiu, Eric Salmon, Christine Bastin, Eric Triau, Steen Hasselbalch, Ian Law, Allan Andersen, Alex Korner,[...]. Ann Neurol 2010
460
23

A nonparametric method for automatic correction of intensity nonuniformity in MRI data.
J G Sled, A P Zijdenbos, A C Evans. IEEE Trans Med Imaging 1998
23

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques.
Milos D Ikonomovic, Enrico R Fantoni, Gill Farrar, Stephen Salloway. Alzheimers Res Ther 2018
16
23

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Willemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, Betty M Tijms, Philip Scheltens, Frans R J Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea,[...]. JAMA 2015
844
23

Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Hyemin Jang, Young Kyoung Jang, Hee Jin Kim, David John Werring, Jin San Lee, Yeong Sim Choe, Seongbeom Park, Juyeon Lee, Ko Woon Kim, Yeshin Kim,[...]. Eur J Nucl Med Mol Imaging 2019
17
23

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
23

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Henryk Barthel, Hermann-Josef Gertz, Stefan Dresel, Oliver Peters, Peter Bartenstein, Katharina Buerger, Florian Hiemeyer, Sabine M Wittemer-Rump, John Seibyl, Cornelia Reininger,[...]. Lancet Neurol 2011
371
23

Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment.
Jae-Hyun Park, Sang Won Seo, Changsoo Kim, Sook Hui Kim, Geon Ha Kim, Sung Tae Kim, Seun Jeon, Jong Min Lee, Seung Jun Oh, Jae Seung Kim,[...]. Neurobiol Aging 2014
53
23

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.
Steven Ng, Victor L Villemagne, Sam Berlangieri, Sze-Ting Lee, Martin Cherk, Sylvia J Gong, Uwe Ackermann, Tim Saunder, Henri Tochon-Danguy, Gareth Jones,[...]. J Nucl Med 2007
169
23

Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Elizabeth Morris, Anastasia Chalkidou, Alexander Hammers, Janet Peacock, Jennifer Summers, Stephen Keevil. Eur J Nucl Med Mol Imaging 2016
116
23

Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Lennart Thurfjell, Johan Lilja, Roger Lundqvist, Chris Buckley, Adrian Smith, Rik Vandenberghe, Paul Sherwin. J Nucl Med 2014
122
23

Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant.
Elizabeth C Mormino, Michael G Brandel, Cindee M Madison, Gil D Rabinovici, Shawn Marks, Suzanne L Baker, William J Jagust. Neuroimage 2012
113
23

Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.
Yi Su, Shaney Flores, Guoqiao Wang, Russ C Hornbeck, Benjamin Speidel, Nelly Joseph-Mathurin, Andrei G Vlassenko, Brian A Gordon, Robert A Koeppe, William E Klunk,[...]. Alzheimers Dement (Amst) 2019
45
23

Spatial Normalization of 18F-Flutemetamol PET Images Using an Adaptive Principal-Component Template
Johan Lilja, Antoine Leuzy, Konstantinos Chiotis, Irina Savitcheva, Jens Sörensen, Agneta Nordberg. J Nucl Med 2019
26
23

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods.
Mark R Battle, Lovena Chedumbarum Pillay, Val J Lowe, David Knopman, Bradley Kemp, Christopher C Rowe, Vincent Doré, Victor L Villemagne, Christopher J Buckley. EJNMMI Res 2018
29
23

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, Dirk L Knol, Wiesje M van der Flier, Bart N M van Berckel, Philip Scheltens, Pieter Jelle Visser, Sander C J Verfaillie, Marissa D Zwan,[...]. JAMA 2015
355
23

A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.
Si Eun Kim, Sookyoung Woo, Seon Woo Kim, Juhee Chin, Hee Jin Kim, Byung In Lee, Jinse Park, Kyung Won Park, Do-Young Kang, Young Noh,[...]. J Alzheimers Dis 2018
24
23

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand,[...]. Lancet Neurol 2013
23

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
15

Centiloid method evaluation for amyloid PET of subcortical vascular dementia.
Hyuk Jin Yun, Seung Hwan Moon, Hee Jin Kim, Samuel N Lockhart, Yearn Seong Choe, Kyung Han Lee, Duk L Na, Jong-Min Lee, Sang Won Seo. Sci Rep 2017
7
28

The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data.
Mark E Schmidt, Ping Chiao, Gregory Klein, Dawn Matthews, Lennart Thurfjell, Patricia E Cole, Richard Margolin, Susan Landau, Norman L Foster, N Scott Mason,[...]. Alzheimers Dement 2015
76
15

Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PET.
Santiago Bullich, Victor L Villemagne, Ana M Catafau, Aleksandar Jovalekic, Norman Koglin, Christopher C Rowe, Susan De Santi. J Nucl Med 2017
34
15

Beta-amyloid imaging with florbetaben.
Osama Sabri, John Seibyl, Christopher Rowe, Henryk Barthel. Clin Transl Imaging 2015
94
15

Clinical Use and Utility of Amyloid Imaging.
Henryk Barthel, Osama Sabri. J Nucl Med 2017
58
15

Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging.
Michael J Pontecorvo, Anupa K Arora, Marybeth Devine, Ming Lu, Nick Galante, Andrew Siderowf, Catherine Devadanam, Abhinay D Joshi, Stephen L Heun, Brian F Teske,[...]. Eur J Nucl Med Mol Imaging 2017
25
15


Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
Gil D Rabinovici, Constantine Gatsonis, Charles Apgar, Kiran Chaudhary, Ilana Gareen, Lucy Hanna, James Hendrix, Bruce E Hillner, Cynthia Olson, Orit H Lesman-Segev,[...]. JAMA 2019
196
15

SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0.
Satoshi Minoshima, Alexander E Drzezga, Henryk Barthel, Nicolaas Bohnen, Mehdi Djekidel, David H Lewis, Chester A Mathis, Jonathan McConathy, Agneta Nordberg, Osama Sabri,[...]. J Nucl Med 2016
91
15

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
Danielle van Westen, Daniel Lindqvist, Kaj Blennow, Lennart Minthon, Katarina Nägga, Erik Stomrud, Henrik Zetterberg, Oskar Hansson. Sci Rep 2016
36
15

Amyloid PET Quantification Via End-to-End Training of a Deep Learning.
Ji-Young Kim, Hoon Young Suh, Hyun Gee Ryoo, Dongkyu Oh, Hongyoon Choi, Jin Chul Paeng, Gi Jeong Cheon, Keon Wook Kang, Dong Soo Lee. Nucl Med Mol Imaging 2019
9
22

Augmenting Amyloid PET Interpretations With Quantitative Information Improves Consistency of Early Amyloid Detection.
Nicholas R Harn, Suzanne L Hunt, Jacqueline Hill, Eric Vidoni, Mark Perry, Jeffrey M Burns. Clin Nucl Med 2017
27
15

Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) multicenter study.
Tomohiko Yamane, Kenji Ishii, Muneyuki Sakata, Yasuhiko Ikari, Tomoyuki Nishio, Kazunari Ishii, Takashi Kato, Kengo Ito, Michio Senda. Eur J Nucl Med Mol Imaging 2017
55
15

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.
V Camus, P Payoux, L Barré, B Desgranges, T Voisin, C Tauber, R La Joie, M Tafani, C Hommet, G Chételat,[...]. Eur J Nucl Med Mol Imaging 2012
153
15

Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study.
John Seibyl, Ana M Catafau, Henryk Barthel, Kenji Ishii, Christopher C Rowe, James B Leverenz, Bernardino Ghetti, James W Ironside, Masaki Takao, Hiroyasu Akatsu,[...]. J Nucl Med 2016
61
15


[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
Juha O Rinne, Dean F Wong, David A Wolk, Ville Leinonen, Steven E Arnold, Chris Buckley, Adrian Smith, Richard McLain, Paul F Sherwin, Gill Farrar,[...]. Acta Neuropathol 2012
63
15

Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.
Stephen Salloway, Jose E Gamez, Upinder Singh, Carl H Sadowsky, Teresa Villena, Marwan N Sabbagh, Thomas G Beach, Ranjan Duara, Adam S Fleisher, Kirk A Frey,[...]. Alzheimers Dement (Amst) 2017
46
15

Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.
Santiago Bullich, John Seibyl, Ana M Catafau, Aleksandar Jovalekic, Norman Koglin, Henryk Barthel, Osama Sabri, Susan De Santi. Neuroimage Clin 2017
63
15

Appropriate reference region selection of 18F-florbetaben and 18F-flutemetamol beta-amyloid PET expressed in Centiloid.
Soo Hyun Cho, Yeong Sim Choe, Seongbeom Park, Young Ju Kim, Hee Jin Kim, Hyemin Jang, Seung Joo Kim, Jun Pyo Kim, Young Hee Jung, Byeong C Kim,[...]. Sci Rep 2020
6
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.